***********************************************************
The Department of Health (DH) today (May 26) endorsed two licensed drug wholesalers, Lanway Ltd (Lanway) and Wings Pharmaceutical Ltd (Wings), to respectively recall from shelves one batch of Scopam S.C. Tablets 10mg (Jen Sheng) (registration number: HK-55061, batch number:3030, expiry date: June 7, 2016) and one batch of Azeic-A Cream 20% (registration number: HK-47622, batch number:000611, expiry date: November 2, 2019) as both pharmaceutical products contain ingredients that have not been approved for use in Taiwan and which may have potential quality issues.
The Taiwan manufacturers of these two products today confirmed the recall as a precautionary measure. The DH's investigation is ongoing.
Scopam S.C. Tablets 10mg (Jen Sheng), containing hyoscine butylbromide, is indicated for the treatment of gastrointestinal spasm. It can only be supplied at pharmacies under the supervision of a registered pharmacist. Azeic-A Cream 20%, containing azelaic acid, is an over-the-counter medicine for the treatment of acne.
"So far, no adverse reports in connection with the above products have been received and we will closely monitor the recall," a spokesman for the DH said.
According to Lanway and Wings, the affected batch of Scopam S.C. Tablets 10mg (Jen Sheng) was supplied to local pharmacies and private doctors, while Azeic-A Cream 20% was supplied to a local medicine company. Both wholesalers have set up hotlines (Lanway: 2850 6181, Wings: 2781 2377) to answer related enquiries.
"People who have purchased and used either of the above products should consult healthcare professionals for advice if in doubt," the spokesman said.
Ends/Tuesday, May 26, 2015
Issued at HKT 18:26
NNNN
